⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707195 | 0.79 | — | — | |
| SCHEMBL1707379 | 0.75 | CES2 (0.41) | — | |
| SCHEMBL2682007 | 0.74 | — | — | |
| SCHEMBL30034103 | 0.74 | — | — | |
| SCHEMBL17477670 | 0.74 | — | — | |
| SCHEMBL9418105 | 0.74 | — | — | |
| SCHEMBL9340037 | 0.74 | — | — | |
| SCHEMBL1706465 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL9718530 | 0.72 | — | — | |
| SCHEMBL9619906 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3114715-B1 | P-DOPING CROSS-LINKING OF ORGANIC HOLE TRANSPORTERS | SIEMENS AG (DE) | 2019-10-30 | — | — | EP | claimed |
| EP-3298639-B1 | FORMULATION CONTAINING AN ORGANIC SEMICONDUCTOR AND A METAL COMPLEX | MERCK PATENT GMBH (DE) | 2021-01-13 | — | — | EP | disclosed |
| CN-107667439-B | Formulations comprising organic semiconductors and metal complexes | 默克专利有限公司 | 2021-01-05 | — | — | CN | disclosed |
| EP-3017488-B1 | OPTOELECTRONIC DEVICE AND METHOD FOR PRODUCING AN OPTOELECTRONIC DEVICE | OSRAM OLED GMBH (DE) | 2020-08-19 | — | — | EP | disclosed |
| US-10581001-B2 | Organic electronic component having a charge carrier generation layer and the use of a zinc complex as a P-type dopant in charge carrier generation layers | OSRAM OLED GMBH (DE) | 2020-03-03 | — | — | US | disclosed |
| US-10566550-B2 | Formulation containing an organic semiconductor and a metal complex | MERCK PATENT GMBH (DE) | 2020-02-18 | — | — | US | disclosed |
| EP-3114715-B1 | P-DOPING CROSS-LINKING OF ORGANIC HOLE TRANSPORTERS | SIEMENS AG (DE) | 2019-10-30 | — | — | EP | disclosed |
| EP-3114191-B1 | SEQUENTIAL FUNCTIONALISATION OF PHOSPHORESCENT EMITTER LAYERS | SIEMENS AG (DE) | 2019-05-08 | — | — | EP | disclosed |
| US-10256422-B2 | Organic electronic component, use of a zinc complex as a p-dopant for organic electronic matrix materials | OSRAM OLED GMBH (DE) | 2019-04-09 | — | — | US | disclosed |
| US-20190074453-A1 | FORMULATION CONTAINING AN ORGANIC SEMICONDUCTOR AND A METAL COMPLEX | MERCK PATENT GMBH (DE) | 2019-03-07 | — | — | US | disclosed |
| US-20170301872-A1 | Organic Electronic Component, use of a Zinc Complex as a P-Dopant for Organic Electronic Matrix Materials | OSRAM OLED GMBH (DE) | 2017-10-19 | — | — | US | disclosed |
| EP-3057151-A1 | PRINCIPAL GROUP METAL COMPLEXES AS P DOTANDS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | Siemens Aktiengesellschaft (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-2845239-B1 | MAIN GROUP METAL COMPLEXES AS P-DOPANTS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SIEMENS AG (DE) | 2016-05-25 | — | — | EP | disclosed |
| US-9283199-B2 | Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms | CIMAS LIMITED (CY) | 2016-03-15 | — | — | US | disclosed |
| US-20160067198-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | CIMAS LIMITED (CY) | 2016-03-10 | — | — | US | disclosed |
| EP-2440198-A2 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | Mardi Medicines Ltd. (IL) | 2012-04-18 | — | — | EP | disclosed |
| US-20110052641-A1 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | MARDI MEDICINES LTD. (IL) | 2011-03-03 | — | — | US | disclosed |
| WO-2010143188-A2 | HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS | MARDI MEDICINES LTD. (IL) | 2010-12-16 | — | — | WO | disclosed |
| US-4226808-A | 1-Aryl-2-dihalogenodeuterioalkanoylamido-1,3-propanediol antibacterial agents | SCHERING CORPORATION (US) | 1980-10-07 | — | — | US | disclosed |
| US-4122115-A | FROM THE ACETIC ACID AND CHLOROSULFONIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-10-24 | — | — | US | disclosed |